Procter & Gamble launched new sensitive-skin products, advanced a restructuring with up to 7,000 job cuts by fiscal 2027, and continued dividend increases and buybacks. These moves balance innovation and productivity against rising costs, $400 million tariff headwinds, and cautious earnings expectations. The company is seen as a safe-haven for risk-off investors due to its growing dividends.